Search

everythinglearnresearchcommunity

for

Search:↓

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Removing both ovaries treated the woman's excess male hormone symptoms.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

A rare ovarian tumor caused high male hormone levels, but surgery fixed it.